These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 8295567
21. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice. Eto M, Mayumi H, Tomita Y, Yoshikai Y, Nishimura Y, Maeda T, Ando T, Nomoto K. J Immunol; 1991 Mar 01; 146(5):1402-9. PubMed ID: 1671578 [Abstract] [Full Text] [Related]
22. Distinct fates of self-specific T cells developing in irradiation bone marrow chimeras: clonal deletion, clonal anergy, or in vitro responsiveness to self-Mls-1a controlled by hemopoietic cells in the thymus. Speiser DE, Chvatchko Y, Zinkernagel RM, MacDonald HR. J Exp Med; 1990 Nov 01; 172(5):1305-14. PubMed ID: 2230645 [Abstract] [Full Text] [Related]
23. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation. Truitt RL, Atasoylu AA. Blood; 1991 Jun 01; 77(11):2515-23. PubMed ID: 2039833 [Abstract] [Full Text] [Related]
24. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Khan A, Tomita Y, Sykes M. Transplantation; 1996 Aug 15; 62(3):380-7. PubMed ID: 8779687 [Abstract] [Full Text] [Related]
25. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. Tomita Y, Khan A, Sykes M. J Immunol; 1994 Aug 01; 153(3):1087-98. PubMed ID: 8027542 [Abstract] [Full Text] [Related]
30. Clonal deletion of self-Mls-reactive thymocytes at the early stage in H-2-compatible but Mls-disparate radiation chimeras. Ogimoto M, Yoshikai Y, Matsuzaki G, Ohga S, Matsumoto K, Nomoto K. Immunology; 1990 Mar 01; 69(3):482-6. PubMed ID: 2312170 [Abstract] [Full Text] [Related]
31. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Johnson BD, Drobyski WR, Truitt RL. Bone Marrow Transplant; 1993 Apr 01; 11(4):329-36. PubMed ID: 8485480 [Abstract] [Full Text] [Related]
32. Cell components required for deletion of an autoreactive T cell repertoire. Fukushi N, Wang BY, Arase H, Ogasawara K, Good RA, Onoé K. Eur J Immunol; 1990 May 01; 20(5):1153-60. PubMed ID: 2113476 [Abstract] [Full Text] [Related]
33. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody. Maeda T, Eto M, Lin T, Nishimura Y, Kong YY, Nomoto K, Nomoto K. J Immunol; 1994 Nov 01; 153(9):4311-20. PubMed ID: 7930630 [Abstract] [Full Text] [Related]